Log in

NASDAQ:RELVReliv International Stock Price, Forecast & News

+0.02 (+0.55 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $3.68
50-Day Range
MA: $3.67
52-Week Range
Now: $3.68
Volume3,102 shs
Average Volume12,011 shs
Market Capitalization$6.44 million
P/E RatioN/A
Dividend YieldN/A
Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:RELV



Sales & Book Value

Annual Sales$35.06 million
Cash Flow$0.08 per share
Book Value$6.36 per share


Net Income$-440,000.00


Market Cap$6.44 million
Next Earnings Date8/14/2020 (Estimated)
OptionableNot Optionable

Receive RELV News and Ratings via Email

Sign-up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter.

Reliv International (NASDAQ:RELV) Frequently Asked Questions

How has Reliv International's stock been impacted by COVID-19 (Coronavirus)?

Reliv International's stock was trading at $3.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RELV stock has increased by 13.2% and is now trading at $3.6783. View which stocks have been most impacted by Coronavirus.

When is Reliv International's next earnings date?

Reliv International is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for Reliv International.

How were Reliv International's earnings last quarter?

Reliv International, Inc (NASDAQ:RELV) released its quarterly earnings results on Friday, May, 15th. The company reported $0.38 EPS for the quarter. The business earned $10.28 million during the quarter. Reliv International had a negative net margin of 1.13% and a negative return on equity of 3.52%. View Reliv International's earnings history.

Has Reliv International been receiving favorable news coverage?

Headlines about RELV stock have been trending somewhat positive this week, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Reliv International earned a news impact score of 0.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news about Reliv International.

Are investors shorting Reliv International?

Reliv International saw a increase in short interest in June. As of June 15th, there was short interest totaling 5,300 shares, an increase of 5,200.0% from the May 31st total of 100 shares. Based on an average daily volume of 12,700 shares, the short-interest ratio is currently 0.4 days. Currently, 0.5% of the company's stock are short sold. View Reliv International's Current Options Chain.

Who are some of Reliv International's key competitors?

What other stocks do shareholders of Reliv International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv International investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Gold Standard Ventures (GSV), Gold Standard Ventures (GSV), Primo Water (PRMW), Rite Aid (RAD), RadNet (RDNT), Ring Energy (REI), Ring Energy (REI) and VIVUS (VVUS).

Who are Reliv International's key executives?

Reliv International's management team includes the following people:
  • Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 77)
  • Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 77)
  • Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 68)
  • Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 45)
  • Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 57)

What is Reliv International's stock symbol?

Reliv International trades on the NASDAQ under the ticker symbol "RELV."

How do I buy shares of Reliv International?

Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Reliv International's stock price today?

One share of RELV stock can currently be purchased for approximately $3.68.

How big of a company is Reliv International?

Reliv International has a market capitalization of $6.44 million and generates $35.06 million in revenue each year. Reliv International employs 156 workers across the globe.

What is Reliv International's official website?

The official website for Reliv International is www.reliv.com.

How can I contact Reliv International?

Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63006. The company can be reached via phone at 636-537-9715 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.